Prevention of <font color="blue">spinal_2</font> <font color="blue">anesthesia_2</font> <font color="blue">-_2</font> <font color="blue">induced_2</font> <font color="blue">hypotension_2</font> <font color="blue">in_1</font> the elderly : <font color="blue">comparison_1</font> between preanesthetic administration of crystalloids , colloids , and no prehydration . 
<br>
<br> The practice of routinely prehydrating patients by infusing a crystalloid or colloid solution ( up to 1.0 L/70 kg ) for prevention of <font color="blue">spinal_2</font> <font color="blue">anesthesia_2</font> <font color="blue">-_2</font> <font color="blue">induced_2</font> <font color="blue">hypotension_2</font> has been challenged recently , after several reports of <font color="blue">failure_1</font> <font color="blue">to_1</font> <font color="blue">demonstrate_1</font> <font color="blue">its_1</font> <font color="blue">efficacy_1</font> in young women . We compared the <font color="blue">incidence_1</font> <font color="blue">and_1</font> <font color="blue">frequency_1</font> <font color="blue">of_1</font> <font color="blue">hypotension_1</font> <font color="blue">and_1</font> <font color="blue">vasopressor_1</font> <font color="blue">therapy_1</font> after spinal anesthesia and no prehydration with crystalloid and colloid prehydration in elderly patients . Eighty - five ASA grade I or II patients ( aged 60 - 89 yr ) for elective total hip replacement were randomized to receive 500 mL crystalloid solution ( Hartmanns , n = 29 ) , 500 mL colloid ( Haemaccel , n = 28 ) , or no prehydration ( n = 28 ) over 10 min prior to spinal anesthesia . <font color="blue">Hypotension_1</font> was defined as a 30% decrease from <font color="blue">baseline_1</font> <font color="blue">systolic_3</font> <font color="blue">blood_3</font> <font color="blue">pressure_3</font> <font color="blue">(_2</font> <font color="blue">BP_2</font> <font color="blue">)_2</font> <font color="blue">or_1</font> <font color="blue">systolic_1</font> <font color="blue"><_1</font> <font color="blue">90_1</font> <font color="blue">mm_1</font> <font color="blue">Hg_1</font> <font color="blue">,_1</font> and was treated with ephedrine 3-mg boluses . Although <font color="blue">absolute_1</font> <font color="blue">systolic_4</font> <font color="blue">BP_5</font> <font color="blue">readings_3</font> were significantly higher in the colloid group between 6 and 30 min ( P < 0.05 ) , the <font color="blue">incidence_1</font> <font color="blue">of_1</font> <font color="blue">hypotension_1</font> was not significantly different between the groups . <font color="blue">The_1</font> <font color="blue">incidence_1</font> <font color="blue">of_1</font> <font color="blue">ephedrine_2</font> <font color="blue">use_2</font> <font color="blue">,_2</font> <font color="blue">incidence_1</font> <font color="blue">of_1</font> <font color="blue">nausea_5</font> <font color="blue">/_5</font> <font color="blue">vomiting_5</font> <font color="blue">,_5</font> <font color="blue">and_2</font> <font color="blue">median_2</font> <font color="blue">total_2</font> <font color="blue">dose_2</font> <font color="blue">of_1</font> <font color="blue">ephedrine_2</font> were similar in all groups . We conclude that , in elderly patients undergoing elective procedures , withholding prehydration is not associated with any greater degree of <font color="blue">hypotension_1</font> <font color="blue">or_1</font> <font color="blue">need_1</font> <font color="blue">for_1</font> <font color="blue">vasopressor_1</font> <font color="blue">therapy_1</font> compared with crystalloid or colloid prehydration .